CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Vivalink wearable devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05655832
NCT05655832N/ACompleted

A Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters and Patient-reported Outcomes for Monitoring Disease Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)

In Brief

A clinical study evaluating Vivalink wearable device for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 77 participants across 11 sites.

Detailed Summary

The purpose of this multicenter, prospective cohort study is to investigate the correlation of real-world sensor-derived biometric data obtained via a wearable device with clinical parameters and patient-reported outcomes (PROs) for monitoring disease activity and predicting exacerbations for participants with Chronic Obstructive Pulmonary Disease (COPD). The cohort of participants with COPD will be followed for 3 months. A calibration cohort with non-COPD participants will be included and followed for 2 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedDec 19, 2022
Enrollment StartDec 5, 2022
Primary CompletionOct 31, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.5 years ago

Interventions

Vivalink wearable devicedevice

a CE marked device modified to add a temperature measurement algorithm in addition to ECG and respiratory rate measurements